Literature DB >> 19664846

Complementary and alternative medicine for psoriasis: a qualitative review of the clinical trial literature.

Nana Smith1, Alex Weymann, Francisco A Tausk, Joel M Gelfand.   

Abstract

BACKGROUND: Patients with psoriasis often inquire about complementary and alternative medicine in an effort to do everything possible to control the disease.
OBJECTIVE: We sought to review the clinical trial literature regarding complementary and alternative medicine for the treatment of psoriasis.
METHODS: We conducted qualitative systematic review of randomized, clinical trials.
RESULTS: Although many randomized controlled trials were found, both the results and the quality of the studies varied. LIMITATIONS: The main limitations were the relatively low quality of studies (as assessed by Jadad scores), lack of inclusion of unpublished studies, and the fact that only one author determined inclusion of studies and assignment of Jadad scores.
CONCLUSION: There is a large body of literature in regard to complementary and alternative medicine for the treatment of psoriasis. More work is necessary before these modalities should be recommended to our patients.

Entities:  

Mesh:

Year:  2009        PMID: 19664846     DOI: 10.1016/j.jaad.2009.04.029

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

Review 1.  Oral herbal medicines for psoriasis: a review of clinical studies.

Authors:  Brian H May; Anthony L Zhang; Wenyu Zhou; Chuan-Jian Lu; Shiqiang Deng; Charlie C L Xue
Journal:  Chin J Integr Med       Date:  2012-04-02       Impact factor: 1.978

2.  A case series of the effects of a novel composition of a traditional natural preparation for the treatment of psoriasis.

Authors:  A Michalsen; O Eddin; A Salama
Journal:  J Tradit Complement Med       Date:  2015-09-19

3.  Ethnopharmacological survey of medicinal plants used by patients with psoriasis in the West Bank of Palestine.

Authors:  Ramzi Shawahna; Nidal Amin Jaradat
Journal:  BMC Complement Altern Med       Date:  2017-01-03       Impact factor: 3.659

4.  Efficacy and safety of HAT1 compared with calcipotriol in the treatment of patients with mild to moderate chronic plaque psoriasis: results from an open-label randomized comparative pilot clinical study.

Authors:  P Alex; S Williams; L Sutton; T Yesudas; C Sutton; S Thomas; M Centola
Journal:  Clin Exp Dermatol       Date:  2019-09-26       Impact factor: 3.470

5.  The effect of Melissa officinalis syrup on patients with mild to moderate psoriasis: a randomized, double-blind placebo-controlled clinical trial.

Authors:  Alireza Yargholi; Leila Shirbeigi; Roja Rahimi; Parvin Mansouri; Mohammad Hossein Ayati
Journal:  BMC Res Notes       Date:  2021-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.